BIOLOGICALLY BASED MATERIALS AND DEVICES

Abstract

The Biologically Based Materials and Devices project will leverage the growing application space of the biological sciences for the development of new DoD capabilities in materials development, threat detection, and warfighter performance. Contained in this project are thrusts that apply biology's unique synthesis capabilities to source DoD-relevant materials and overcome current limitations in accessing, scaling, and distributing critical resources to achieve overmatch. Programs in this project also enable in situ and stand-off detection and mitigation of biological, chemical, traditional, and emerging threats against the warfighter, the food supply, and other targets. This Project also includes efforts to develop novel biological technologies for maintaining human combat performance. This Project also supports innovation and robust transition planning in the technology cycle by working with entrepreneurs to increase the likelihood that DARPA funded technologies take root in the U.S. and provide new capabilities for national defense. This Project includes FY 2020 CARES Act funding in the amount of $24.0 million to test ultra-sensitive methods for diagnosing COVID-19, discover completely novel clustered regularly interspaced short palindromic repeats (CRISPR)-based therapies against COVID-19, and assess the efficacy of Food and Drug Administration (FDA)-approved therapeutic drug candidates for treatment of COVID-19.

Open PDF

Document Details

Document Type
Project
Publication Date
Oct 01, 2022
Source ID
MBT-02_0602715E_2_0400_PB_2022

Tags

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Military Science and Technology Research and Modernization.
  • Molecular Genetics

Technology Areas

  • Biotechnology
  • Space

Related Documents